Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Soman increases neuronal COX-2 levels: possible link between seizures and protracted neuronal damage.

Angoa-PĂ©rez M, Kreipke CW, Thomas DM, Van Shura KE, Lyman M, McDonough JH, Kuhn DM.

Neurotoxicology. 2010 Dec;31(6):738-46. doi: 10.1016/j.neuro.2010.06.007.

2.

Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure.

Prager EM, Aroniadou-Anderjaska V, Almeida-Suhett CP, Figueiredo TH, Apland JP, Braga MF.

Neurotoxicology. 2013 Sep;38:84-90. doi: 10.1016/j.neuro.2013.06.006.

PMID:
23817175
3.

Combined diazepam and HDAC inhibitor treatment protects against seizures and neuronal damage caused by soman exposure.

Rossetti F, de Araujo Furtado M, Pak T, Bailey K, Shields M, Chanda S, Addis M, Robertson BD, Moffett M, Lumley LA, Yourick DL.

Neurotoxicology. 2012 Jun;33(3):500-11. doi: 10.1016/j.neuro.2012.02.010.

PMID:
22387230
4.

The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: relation to anxiety-like behavior.

Prager EM, Aroniadou-Anderjaska V, Almeida-Suhett CP, Figueiredo TH, Apland JP, Rossetti F, Olsen CH, Braga MF.

Neuropharmacology. 2014 Jun;81:64-74. doi: 10.1016/j.neuropharm.2014.01.035.

5.

Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus.

Aroniadou-Anderjaska V, Figueiredo TH, Apland JP, Qashu F, Braga MF.

Neurotoxicology. 2009 Sep;30(5):772-6. doi: 10.1016/j.neuro.2009.06.011.

6.

Anatomical localization and time course of Fos expression following soman-induced seizures.

Zimmer LA, Ennis M, el-Etri M, Shipley MT.

J Comp Neurol. 1997 Feb 24;378(4):468-81.

PMID:
9034904
7.

Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman.

McDonough JH Jr, Clark TR, Slone TW Jr, Zoeffel D, Brown K, Kim S, Smith CD.

Neurotoxicology. 1998 Jun;19(3):381-91.

PMID:
9621344
8.

Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology.

Apland JP, Figueiredo TH, Qashu F, Aroniadou-Anderjaska V, Souza AP, Braga MF.

Neurotoxicology. 2010 Sep;31(5):485-92. doi: 10.1016/j.neuro.2010.05.014.

9.

Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro.

Apland JP, Aroniadou-Anderjaska V, Braga MF.

Neuroscience. 2009 Mar 3;159(1):380-9. doi: 10.1016/j.neuroscience.2008.11.053.

10.

Magnetic resonance imaging predicts neuropathology from soman-mediated seizures in the rodent.

Bhagat YA, Obenaus A, Hamilton MG, Kendall EJ.

Neuroreport. 2001 May 25;12(7):1481-7.

PMID:
11388434
11.

Caramiphen edisylate as adjunct to standard therapy attenuates soman-induced seizures and cognitive deficits in rats.

Schultz MK, Wright LK, de Araujo Furtado M, Stone MF, Moffett MC, Kelley NR, Bourne AR, Lumeh WZ, Schultz CR, Schwartz JE, Lumley LA.

Neurotoxicol Teratol. 2014 Jul-Aug;44:89-104. doi: 10.1016/j.ntt.2014.06.002.

PMID:
24946037
12.

Pharmacological modulation of soman-induced seizures.

McDonough JH Jr, Shih TM.

Neurosci Biobehav Rev. 1993 Summer;17(2):203-15.

PMID:
8515903
13.
14.

The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology.

Figueiredo TH, Qashu F, Apland JP, Aroniadou-Anderjaska V, Souza AP, Braga MF.

J Pharmacol Exp Ther. 2011 Feb;336(2):303-12. doi: 10.1124/jpet.110.171835.

15.

Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats.

de Araujo Furtado M, Lumley LA, Robison C, Tong LC, Lichtenstein S, Yourick DL.

Epilepsia. 2010 Aug;51(8):1503-10. doi: 10.1111/j.1528-1167.2009.02478.x.

16.

Soman-induced seizures rapidly activate astrocytes and microglia in discrete brain regions.

Zimmer LA, Ennis M, Shipley MT.

J Comp Neurol. 1997 Feb 24;378(4):482-92.

PMID:
9034905
17.

A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists.

Miller SL, Aroniadou-Anderjaska V, Figueiredo TH, Prager EM, Almeida-Suhett CP, Apland JP, Braga MF.

Toxicol Appl Pharmacol. 2015 Apr 15;284(2):204-16. doi: 10.1016/j.taap.2015.02.008.

18.

Time course and regional expression of C-FOS and HSP70 in hippocampus and piriform cortex following soman-induced seizures.

Baille-Le Crom V, Collombet JM, Burckhart MF, Foquin A, Pernot-Marino I, Rondouin G, Lallement G.

J Neurosci Res. 1996 Sep 1;45(5):513-24.

PMID:
8875316
19.

Neuropharmacological specificity of brain structures involved in soman-induced seizures.

Skovira JW, Shih TM, McDonough JH.

Neurotoxicology. 2012 Jun;33(3):463-8.

PMID:
22774227
20.

LY293558 prevents soman-induced pathophysiological alterations in the basolateral amygdala and the development of anxiety.

Prager EM, Figueiredo TH, Long RP 2nd, Aroniadou-Anderjaska V, Apland JP, Braga MF.

Neuropharmacology. 2015 Feb;89:11-8. doi: 10.1016/j.neuropharm.2014.08.014.

Items per page

Supplemental Content

Support Center